| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |